Albemarle Corp buy Scotiabank
Start price
14.05.26
/
50%
€163.80
Target price
14.05.27
-
Performance (%)
-35.87%
Price
16:49
€105.05
Summary
This prediction is currently active. The BUY prediction by Scotiabank for Albemarle Corp is performing very badly with a performance of -35.87%. This prediction currently runs until 14.05.27. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionAlbemarle is a specialty chemical company that produces and markets lithium, bromine, and other specialty chemicals globally. The company's products are used in a wide range of applications, including energy storage, flame retardants, pharmaceuticals, and agricultural solutions. Albemarle's lithium business has been a key driver of growth in recent years due to increasing demand for lithium-ion batteries used in electric vehicles and other technologies. The company has a market capitalization of around $11 billion and is listed on the New York Stock Exchange under the ticker symbol ALB.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Albemarle Corp | 5.454% | 5.454% |
| iShares Core DAX® | 3,26 % | 2,07 % |
| iShares Nasdaq 100 | 5,70 % | -0,60 % |
| iShares Nikkei 225® | 7,77 % | -4,75 % |
| iShares S&P 500 | 2,80 % | 2,25 % |
Comments by Scotiabank for this prediction
In the thread Albemarle Corp diskutieren
Albemarle (ALB) had its "outperform" rating reaffirmed by Scotiabank.
Ratings data for ALB provided by MarketBeat